Hier finden Sie wissenschaftliche Publikationen aus den Fraunhofer-Instituten.

Diagnostic platform for automated personalized chemosensitive assays

Poster at MedTech Pharma 2012, Medizin Innovativ, Kongress und Ausstellung; 4.-5. Juli 2012, Nürnberg
: Heymer, Andrea; Siegert, Caroline; Schork, Evelyn; Steiner, Christof; Reis, Christian

Poster urn:nbn:de:0011-n-2235352 (4.3 MByte PDF)
MD5 Fingerprint: 3da826fdabcc2f51d20ddc92f10a6574
Erstellt am: 11.1.2013

2012, 1 S.
Kongress "MedTech Pharma" <2012, Nürnberg>
Poster, Elektronische Publikation
Fraunhofer IPA ()
automatisiertes Probenhandling; High Throughput Screening (HTS); DiagnoSYS; personalisierte Medizin; Krebs; biomedizinische Technik; Prozessautomatisierung

Individualized chemosensitivity assays as part of personalized cancer therapy aims to identify the most potent combination of chemotherapeutics for an optimal therapy. The fully automated DiagnoSYS platform technology provides a system for the efficient use of chemosensitivity assays. Integrated tissue preparation, combined with magnetic cell enrichment and luminescence based cell vitality measurements are the main quality influencing process steps. The platform is segmented, based on the internationally accepted SBS-format. Therefore, all processing steps can be exchanged fast and easily and will allow to process different assay approaches on the same platform. Due to modular programming, further processing steps can be implemented easily. This automated platform facilitates the optimization and standardization of personalized assays and reduces costs.